Unknown

Dataset Information

Uncovering elevated tau TPP motif phosphorylation in the brain of Alzheimer's disease patients.


ABSTRACT:

Introduction

A wide array of post-translational modifications of the tau protein occurs in Alzheimer's disease (AD) and they are critical to pathogenesis and biomarker development. Several promising tau markers, pT181, pT217, and pT231, rely on increased phosphorylation within a common molecular motif threonine-proline-proline (TPP).

Methods

We validated new and existing antibodies against pT217, pT231, pT175, and pT181, then combined immunohistochemistry (IHC) and immunoassays (ELISA) to broadly examine the phosphorylation of the tau TPP motif in AD brains.

Results

The tau burden, as examined by IHC and ELISA, correlates to Braak stages across all TPP sites. Moreover, we observed regional variability across four TPP motif phosphorylation sites in multiple brains of s

SUBMITTER: Bellier JP 

PROVIDER: S-EPMC10947957 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature